BioRegenx, Inc. (BRGX)
OTCMKTS · Delayed Price · Currency is USD
0.0108
-0.0013 (-10.74%)
At close: Mar 5, 2026
BioRegenx Market Cap
BioRegenx has a market cap or net worth of $10.39 million as of March 6, 2026. Its market cap has decreased by -66.58% in one year.
Market Cap
10.39M
Enterprise Value
12.60M
Revenue
1.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since March 12, 2024, BioRegenx's market cap has decreased from 49.89M to 10.39M, a decrease of -79.18%. That is a compound annual growth rate of -54.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 10.39M | -16.28% |
| Dec 31, 2025 | 12.41M | 44.15% |
| Dec 31, 2024 | 8.61M | -82.74% |
| Mar 12, 2024 | 49.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaso Corporation | 29.91M |
| Veri Medtech Holdings | 20.20M |
| CareView Communications | 14.89M |
| Welsis | 12.66M |
| Resilient Healthcare | 12.13M |
| Pharma-Bio Serv | 11.22M |
| DATATRAK International | 9.97M |
| PreAxia Health Care Payment Systems | 9.47M |